Literature DB >> 6153979

Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-liver-cell-conditioned medium.

A C Moses, S P Nissley, P A Short, M M Rechler, J M Podskalny.   

Abstract

Multiplication-stimulating activity (MSA) refers to a family of insulin-like growth factors that have been purified from serum-free medium conditioned by a Buffalo rat liver cell line (BRL-3A). Using Dowex ion-exchange chromatography, gel chromatography on Sephadex G-75, and preparative disc acrylamide gel electrophoresis, several polypeptides with the full biological multiplication-stimulating activity have been isolated. One of these polypeptides, designated MSA II-1, previously has been used to study the relationship of the activity to the insulin-like growth factors (somatomedins) purified from human plasma. Polypeptide II-1 is a single chain polypeptide of molecular weight 8700. Glycine is the COOH-terminal amino acid. Edman degradation of carboxymethylated MSA II-1 did not reveal a free NH2-terminus. A polypeptide of lower molecular weight than MSA II-1 has also been purified. This polypeptide (MSA III-2) has been shown to be more potent than MSA II-1 in the rat-liver-membrane radioreceptor assay and in a competitive binding assay utilizing the rat-serum somatomedin-binding protein(s). The relationship of these various polypeptides has been investigated by gel filtration in guanidine hydrochloride and by acrylamide gel electrophoresis of the reduced and native polypeptides.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153979     DOI: 10.1111/j.1432-1033.1980.tb04325.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  27 in total

Review 1.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

2.  Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum.

Authors:  G L Francis; L C Read; F J Ballard; C J Bagley; F M Upton; P M Gravestock; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

3.  Survival and proliferation of rat gonocytes in vitro.

Authors:  F M van Dissel-Emiliani; M de Boer-Brouwer; E R Spek; J A van der Donk; D G de Rooij
Journal:  Cell Tissue Res       Date:  1993-07       Impact factor: 5.249

4.  Mitogenic polypeptide of the mammalian seminiferous epithelium: biochemical characterization and partial purification.

Authors:  L A Feig; M Klagsbrun; A R Bellvé
Journal:  J Cell Biol       Date:  1983-11       Impact factor: 10.539

5.  Receptors for multiplication-stimulating activity (MSA) on rabbit chondrocytes.

Authors:  I K Ashton; J H Soul
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

6.  Amino acid sequence of a variant pro-form of insulin-like growth factor II.

Authors:  P P Zumstein; C Lüthi; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas.

Authors:  P H Wang; F Beguinot; R J Smith
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

8.  Insulin-like growth factors (IGF) I and II in diabetic pregnancy: suppression of normal pregnancy-induced rise of IGF-I.

Authors:  B Bhaumick; A D Danilkewich; R M Bala
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

9.  Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1.

Authors:  L C Read; F J Ballard; G L Francis; R C Baxter; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

10.  Insulin acts as a somatomedin analog in stimulating myoblast growth in serum-free medium.

Authors:  J R Florini; D Z Ewton
Journal:  In Vitro       Date:  1981-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.